Repare Therapeutics
RPTX
RPTX was delisted on the 27th of January, 2026.
78 hedge funds and large institutions have $379M invested in Repare Therapeutics in 2023 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 25 reducing their positions, and 7 closing their positions.
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
16% more capital invested
Capital invested by funds: $327M → $379M (+$52.5M)
14% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 7
6.19% more ownership
Funds ownership: 78.91% → 85.1% (+6.2%)
1% more funds holding
Funds holding: 77 → 78 (+1)
8% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 25
35% less call options, than puts
Call options by funds: $87K | Put options by funds: $133K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VVM
Versant Venture Management
San Francisco,
California
|
+$27.3M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.55M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$2.11M |
| 4 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$1.92M |
| 5 |
NAMA
Nikko Asset Management Americas
New York
|
+$1.66M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$3.1M |
| 2 |
SCM
Sio Capital Management
New York
|
-$1.57M |
| 3 |
BlackRock
New York
|
-$1.33M |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$1.13M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$1.08M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
US Bancorp
Minneapolis,
Minnesota
| $5.64K | +$2.13K | +207 | +63% |
|
|
ACM
77
Aquatic Capital Management
Chicago,
Illinois
| $4K | -$3.09K | -300 | -43% |
|
78
Daiwa Securities Group
Tokyo,
Japan
| $1K | – | – | – |
|
79
AQR Capital Management
Greenwich,
Connecticut
| – | -$306K | -31,126 | Closed |
|
|
N
80
Nuveen
Charlotte,
North Carolina
| – | -$235K | -23,846 | Closed |
|
81
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$223K | -22,710 | Closed |
|
82
Invesco
Atlanta,
Georgia
| – | -$102K | -10,315 | Closed |
|
|
VEA
83
Virtus ETF Advisers
New York
| – | -$67K | -6,808 | Closed |
|
|
SOW
84
State of Wyoming
Cheyenne,
Wyoming
| – | -$53.9K | -5,477 | Closed |
|
|
NECFA
85
New England Capital Financial Advisors
Meriden,
Connecticut
| – | -$119 | -12 | Closed |
|
RPTX Hedge Fund Activity: Q2 2023 in Review
78 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Repare Therapeutics (RPTX) for Q2 2023, worth a combined $379M — up 16% from $327M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new RPTX positions and 7 closed out — a net gain of 1 holder — while 23 added to existing stakes and 25 trimmed.
The largest buyer was Versant Venture Management, opening a new position worth an estimated $27.3M. The largest seller was Millennium Management, cutting an estimated $3.1M.
- 78 institutional investors held Repare Therapeutics (RPTX) as of Q2 2023, up from 77 in Q1 2023.
- Funds reported $379M of Repare Therapeutics stock for Q2 2023, up 16% quarter-over-quarter.
- 8 funds opened new Repare Therapeutics positions in Q2 2023 and 7 closed out, a net change of +1 holder.
- The largest Repare Therapeutics buyer in Q2 2023 was Versant Venture Management, an estimated $27.3M added.
- The largest Repare Therapeutics seller in Q2 2023 was Millennium Management, an estimated $3.1M sold.
Based on aggregated 13F filings for Q2 2023.